Changes of plasma proteins after immunoadsorption using Ig-Adsopak columns in patients with myasthenia gravis

Transfusion and Apheresis Science

Volumn 30, Issue 2, 2004, Pages 125-129

  Pták, Jan ^a  

^a UNIVERSITY HOSPITAL OSTRAVA   (Czech Republic)

Author keywords

Immunoadsorption treatment; Myasthenia gravis

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PLASMA PROTEIN;

ARTICLE; BINDING AFFINITY; CLINICAL ARTICLE; CONTROLLED STUDY; HEMOCONCENTRATION; HUMAN; IMMUNOADSORPTION; MEASUREMENT; MYASTHENIA GRAVIS; PATIENT; PLASMA VOLUME; PROTEIN ANALYSIS; PROTEIN BINDING;

AUTOANTIBODIES; BLOOD PROTEINS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOGLOBULINS; IMMUNOSORBENT TECHNIQUES; MYASTHENIA GRAVIS; PLASMAPHERESIS; RECEPTORS, CHOLINERGIC; TIME FACTORS;

EID: 1942486760     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2003.11.005     Document Type: Article

References (15)

1. Agishi T. The current status of extracorporeal immunomodulation. Transfus. Sci. 3:1996;439-444.
2. Splendiani G., Passalacquua S., Barbera G., Sturniolo G., Constanzi S., Fulignati P.et al. Semi-selective immunoadsorption treatment in myasthenia gravis. Biomater., Art Cells Immob. Biotech. 5:1992;1145-1151.
3. Takamori M., Ide Y. Specific removal of antiacetylcholine receptor antibodies in patients with myasthenia gravis. Transfus. Sci. 3:1996;445-453.
4. Berta E., Confalonieri P., Simoncini O., Barnardi G., Busnach G., Mantegazza R.et al. Removal of antiacetylcholine receptor antibodies by protein-A immunoadsorption in myasthenia gravis. Int. J. Artif. Organs. 11:1994;603-608.
5. Kurkus I, Thysell H, Lindgren A, Bradvik B. In: Proceedings of the 12th ESFH Congress, Malmö, Sweden, 1999
6. Schneider K.M. Plasmapheresis and immunoadsorption: different techniques and their current role in medical therapy. Kidney Int. (Suppl. 64):1998;S-61-S-65.
7. Toepfer M., Schiffl H., Sitter T., Pongratz D., Müller-Felber W. Extracorporeal antibody elimination in neuroimmunological diseases. Ther. Apher. 3:1999;268-270.
8. Toepfer M., Sitter T., Burchardi C., Held E., Schiffl H. Klinische immunoadsorption. Dtsch. Med. Wschr. 124:1999;461-465.
9. Borberg H., Jimenez C., Belák M., Haupt W.F., Späth P. Treatment of autoimmune disease by immunomodulation through extracorporeal elimination and intravenous immunoglobulin. Transfus. Sci. 4:1994;409-418.
10. Matic G., Hofmann D., Winkler R., Tiess M., Michelsen A., Schneidewind J.M.et al. Removal of immunoglobulins by a protein A versus an antihuman immunoglobulin G-based system: evaluation of 602 sessions of extracorporeal immunoadsorption. Artif. Organs. 2:2000;103-107.
11. Vamvakas C.E., Pineda A.A. Selective extraction of plasma components. McLeod B.C., Price T.H., Drew M.J. Apheresis: principle and practice. 1997;375-407 AABB Press, Bethesda, MB.
12. Braun N., Bosch T. Immunoadsorption, current status and future developments. Exp. Opin. Invest. Drugs. 9:2000;2017-2037.
13. Blaha V., Solichova D., Zadak Z., Blaha M., Havel E., Vyroubal P.et al. Immunoadsorption in the treatment of hypercholesterolemia: five years of research and clinical experience. Nutrition. 12:2002;211.
14. Blaha M., Zadak Z., Blaha V., Havel E., Vyroubal P., Pivokonska M.et al. LDL-apheresis as a method of extracorporal LDL-elimination. Ateroskleroza. 5:2001;19-23.
15. Terman D.S., Tavel T., Peety D., Racic R., Buffaloe G. Specific removal of antibody by extracorporeal circulation over antigen-immobilized in colloidon-charcoal. Clin. Exp. Immunol. 28:1977;180-188.